AI Article Synopsis
- The COVID-19 pandemic has created urgent needs for effective diagnostics, treatments, and vaccines, but it also poses new challenges like the risk of co-infections.
- Co-infections in COVID-19 patients have led to serious complications, such as secondary systemic mycoses, which can result in severe health issues and increased mortality.
- This review aims to raise awareness about the high risk of these secondary infections among individuals already weakened by COVID-19.
Article Abstract
As the global COVID-19 pandemic spreads worldwide, new challenges arise in the clinical landscape. The need for reliable diagnostic methods, treatments and vaccines for COVID-19 is the major worldwide urgency. While these goals are especially important, the growing risk of co-infections is a major threat not only to the health systems but also to patients' lives. Although there is still not enough published statistical data, co-infections in COVID-19 patients found that a significant number of patients hospitalized with COVID-19 developed secondary systemic mycoses that led to serious complications and even death. This review will discuss some of these important findings with the major aim to warn the population about the high risk of concomitant systemic mycoses in individuals weakened by COVID-19.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2217/fmb-2020-0156 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!